Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
amgen
boston blog main
boston top stories
cholesterol
inclisiran
life sciences
national blog main
national top stories
new york blog main
3
×
new york top stories
pcsk9
3
×
praluent
regeneron pharmaceuticals
repatha
3
×
san francisco blog main
san francisco top stories
3
×
biotech
boulder/denver blog main
boulder/denver top stories
detroit blog main
detroit top stories
indiana blog main
indiana top stories
ldl
medco
medicines co.
mt sinai hospital
national
prashant vaishnava
raleigh-durham blog main
raleigh-durham top stories
san diego blog main
san diego top stories
sanofi
seattle blog main
seattle top stories
texas blog main
texas top stories
trial
wisconsin blog main
What
cholesterol
3
×
drug
lowering
abbvie’s
aces
announced
barbecuing
big
bio
camping
cardiologist
center
ceo
check
conference
day
drugs
expensive
faces
financial
flexible
flop
foe
healthcare
hint
hit
inclisiran
inhibitors
j
j’s
key
known
labor
meant
medco
medicine
medicines
monday
nasdaq
new
Language
unset
Current search:
cholesterol
×
repatha
×
" new york blog main "
×
pcsk9
×
" san francisco top stories "
×
@xconomy.com
5 years ago
As Cholesterol Drug Aces Big Test, MedCo CEO Open to Flexible Pricing
@xconomy.com
5 years ago
Bio Roundup: Cholesterol Check, J&J’s Opioid Hit, AbbVie’s Flop & More
@xconomy.com
5 years ago
New PCSK9 Cholesterol Drug Faces Tough Foe. (Hint: Not Cholesterol.)